Boeing Could Get Wings, But Dow Jones Lags: What’s Next?
While the Nasdaq and the SPDR S&P 500 (NYSE: SPY) are running in blue skies, the Dow Jones Industrial Average has struggled to trade back toward its May 10 all-time high of 35,091.
Jim Cramer Says Moderna Stock Is ‘Too High At This Point’
CNBC host Jim Cramer said that Moderna Inc.’s (NASDAQ: MRNA) stock is “too high at this point” and the biotechnology company’s crucial test is whether it can offer personalized cancer vaccines in time to offset the decline in COVID-19 vaccine sales.
Is Now The Time To Buy Into GameStop, Orbsat, Or Amazon?
The following three stocks are on the radar of retail investors and day traders early Wednesday.
Clover Health Tops WallStreetBets-Interest Chart Today; GameStop, AMC Also In Spotlight
SPDR S&P 500 ETF Trust (NYSE: SPY) and Clover Health Investments Corp. (NASDAQ: CLOV) are seeing the highest interest on Reddit’s r/WallStreetBets forum, while GameStop Corp. (NYSE:
Here’s Why Carnival’s Stock Looks Ready To Tumble
Carnival Corp. (NYSE: CCL) shares traded lower Tuesday after the company announced a tender offer for its 11.5% senior secured notes due 2023 subject to refinancing conditions. The stock may also be falling with the sector as other cruise companies are falling.
Disney And Caterpillar Lead The Dow Jones Lower Tuesday
U.S. indices were trading lower Tuesday as stocks slightly pull back following last week's strength.
What’s Happening With Wells Fargo And Bank Of America Shares Today?
Shares of banks and financial services companies, including Wells Fargo & Co (NYSE: WFC) and Bank of America Corp (NYSE: BAC), are trading lower Tuesday amid a drop in bond yields.
Why Clover Health Investments Shares Are Getting Hammered Today
Clover Health Investments Corp (NASDAQ: CLOV) shares are trading lower by 14.4% at $10.02 Tuesday afternoon following the end of the company's 180-day share lock-up period.
ChemoCentryx Stock Is Approaching A Key Level
ChemoCentryx Inc. (NASDAQ: CCXI) shares traded higher Tuesday after the company announced it filed an amendment to its New Drug Application for avacopan for the treatment of anti-neutrophil cytoplasmic yutoantibody associated vasculitis. The U.S.
What’s Next For Ocugen Stock As It Nears Key Resistance Level?
Ocugen Inc. (NASDAQ: OCGN) shares traded higher Tuesday after the company announced that its coronavirus vaccine co-development partner Bharat Biotech reported Phase 3 results demonstrating 77.8% protection against overall disease.